01 1Suven Pharmaceuticals Limited
01 1Danofloxacin Mesylate
01 1India
NDC Package Code : 68022-7524
Start Marketing Date : 2020-12-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Danofloxacin Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Danofloxacin Mesylate, including repackagers and relabelers. The FDA regulates Danofloxacin Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Danofloxacin Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Danofloxacin Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Danofloxacin Mesylate supplier is an individual or a company that provides Danofloxacin Mesylate active pharmaceutical ingredient (API) or Danofloxacin Mesylate finished formulations upon request. The Danofloxacin Mesylate suppliers may include Danofloxacin Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Danofloxacin Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Danofloxacin Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Danofloxacin Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Danofloxacin Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Danofloxacin Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Danofloxacin Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Danofloxacin Mesylate suppliers with NDC on PharmaCompass.
We have 1 companies offering Danofloxacin Mesylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
